Consumer and HCP data? Check. Multiple identity solutions? Yes. AI platforms? We have those too.
Today’s pharma marketers aren’t struggling because they lack data or tools. They are struggling because their strategy is fragmented. Successfully navigating today’s pharma marketing ecosystem requires intelligence architecture that connects disparate data into one continuously learning system.
Butler/Till raised awareness of this need with a PharmaCX 2026 panel, entitled, “Identity Crisis, Solved:The Case for Unified Data and Intelligence in the Evolution of Pharma Marketing”. Our Chief Product Officer, Manny Puentes, joined Sayantan Dasgupta, Gilead’s Director of Marketing Sciences, Krystal Olivieri, Chief Strategy Officer at Experian Marketing Services, and Drew Teller, Director of Strategic Media Partnerships at OptimizeRX, for a lively discussion moderated by theorist, Richard Schwartz.
They shared what marketers must recognize to reduce fragmentation, strengthen governance, and accelerate decision-making in pharma marketing. We summarize the key takeaways below.
- Identity is the Foundation of Effective Marketing
In marketing, “identity” is the power to recognize and understand a consumer across various channels and interactions. Once the goal, uncovering identity is now a foundational step towards unlocking a holistic view of the target audience. Marketers that can connect fragmented HCP, pharma, and consumer data can deploy strategies that support deeper personalization, more effective cross-channel storytelling, and more accurate campaign measurement.
- Data Integration Enables Real Time Decisions
One of the biggest downsides of data fragmentation is it dulls marketers’ instincts. After all, it is difficult to determine where the next banner ad should appear or what the next email should say without a comprehensive view of consumer behavior. Integrated data can help marketers understand what’s happening in real time, so they can adjust accordingly to enhance the consumer experience as it unfolds.
- AI and Agentic Capabilities can Take Data to Intelligence
Data answers, “what is happening?”, while intelligence answers, “what’s next?” AI and machine learning can connect these two pieces, helping marketers turn information into action. More specifically, agentic AI can help marketers make faster, smarter decisions about audience targeting, budget allocation, and campaign optimization.
- Measurement and Optimization Should Be Built into Campaign Strategy
Traditionally, marketers would measure a campaign after it ran, using insights to inform future campaigns. AI brings measurement into the campaign planning process, allowing marketers to to optimize spend and efficacy from the start.
- Take Inventory before Investing in Advanced AI
From transforming data into intelligence to introducing measurement earlier in the process, AI offers exciting capabilities for pharma marketers seeking a competitive edge in today’s ecosystem. However, it’s important to establish the starting point before investing in advanced AI. Panelists urged marketers to ask themselves the following questions before launching a campaign:
- What data do we actually have?
- What is our strategy?
- How can we connect our existing systems more effectively?
- Is our current technology working together to generate actionable insights?
Knowing where you stand is crucial for building a cost-effective system that achieves results.
Bottom Line:
Identity is the thread that weaves fragmented data and AI together, helping marketers move brand-centric tactics to a customer-centric approach. Fortunately, we have the technology to connect the data, identity solutions, and systems to uncover insights, personalize campaigns, allocate budgets and measure performance in real time. The opportunity lies in using it wisely.
